Hervé Lebrec
About Hervé Lebrec
Hervé Lebrec serves as the Vice President of Development Sciences at Sonoma Biotherapeutics, having previously held significant roles at Amgen and 3M. He possesses extensive academic qualifications in toxicology and pharmacy, including a Ph.D. and a Diplomate from the American Board of Toxicology.
Current Role at Sonoma BioTherapeutics
Hervé Lebrec serves as the Vice President of Development Sciences at Sonoma BioTherapeutics. He has held this position since 2021, contributing to the company's focus on developing innovative biotherapeutic solutions. His role involves overseeing scientific development processes and ensuring the advancement of therapeutic candidates.
Previous Experience at Amgen
Lebrec worked at Amgen for a total of 15 years, holding various positions. He served as Scientific Director from 2006 to 2020, where he was involved in significant scientific initiatives in San Francisco. Following this, he was promoted to Executive Director, a role he held for one year until 2021 in South San Francisco.
Experience at 3M
Prior to his tenure at Amgen, Lebrec worked at 3M for five years, from 2000 to 2005. He held the positions of Research Specialist and Advanced Research Specialist in Saint Paul, MN. He later became the Manager of Pathology and Toxicology for a brief period in 2005 to 2006.
Educational Background in Toxicology
Lebrec has a strong educational foundation in toxicology. He earned a Master's Degree in Toxicology from Université Paris Cité in 1989. He then completed his Doctorate in Pharmacy and a Doctor of Philosophy (Ph.D.) in Toxicology at Paris-Sud University (Paris XI) in 1992. Additionally, he achieved Diplomate status from the American Board of Toxicology in 2001.